Search bioRxiv⌕ Search

Biology subjects

DeMoya-Valenzuela, N.

Publications and source records attributed to DeMoya-Valenzuela, N..

2 recordsLinked to original sources

Benchmarking Free Energy Computational Methods for Revealing the Interactions Driving PARP1 Selective Inhibition

Accurate prediction of inhibitor selectivity across protein paralogues remains a central challenge in computational drug discovery. Here, we systematically benchmark three computational methods--Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA), free energy perturbation (FEP) and potential of mean force (PMF) calculations--in their ability to recapitulate PARP1 versus PARP2 selectivity for eight clinically relevant PARP enzyme inhibitors used in ovarian, breast and prostate tumors among others. We demonstrate how MM/PBSA calculations offer rapid and qualitative insights, but show pronounced sensitivity to the chosen static conformational pose, being particularly challenging for ligands with subtle energetic differences between distinct protein paralogues. In contrast, both FEP and PMF calculations using atomistic models with explicit solvent result in substantially improved agreement with experimental binding affinities. The FEP method exhibits the strongest quantitative correlation with experimental binding free energy differences, remarkably reproducing selectivity trends even among nearly isoenergetic complexes. Notably, our structural contact analysis reveals how contact connectivity controls ligand selectivity, providing valuable mechanistic and molecular insight into the key residues that stabilize each inhibitor in both protein enzymes. Together, our multi-method computational study contributes to elucidate potential chemical modifications across the ligand chemical space to enhance potency and specificity, informing the future design and evaluation of selective inhibitors for precision oncology, including therapies targeting homologous recombination-deficient cancers.

bioinformatics↗

Dominant induction of the inflammasome by the SARS-CoV-2 accessory protein ORF9b, abrogated by small-molecule ORF9b homodimerization inhibitors

Viral accessory proteins play critical roles in viral escape form host innate immune responses and in viral inflammatory pathogenesis. Here we show that the SARS-CoV-2 accessory protein, ORF9b, but not other SARS-CoV-2 accessory proteins (ORF3a, ORF3b, ORF6, ORF7, ORF8, ORF9c, ORF10), strongly activates inflammasome-dependent caspase-1 in A549 lung carcinoma cells and THP-1 monocyte-macrophage cells. Exposure to lipopolysaccharide (LPS) and ATP additively enhanced the activation of caspase-1 by ORF9b, suggesting that ORF9b and LPS follow parallel pathways in the activation of the inflammasome and caspase-1. Following rational in silico approaches, we have designed small molecules capable of inhibiting the homodimerization of ORF9b, which experimentally inhibited ORF9b-ORF9b homotypic interactions, caused mitochondrial eviction of ORF9b, inhibited ORF9b-induced activation of caspase-1 in A549 and THP-1 cells, cytokine release in THP-1 cells, and restored type I interferon (IFN-I) signaling suppressed by ORF9b in both cell models. These small molecules are first-in-class compounds targeting a viral accessory protein critical for viral-induced exacerbated inflammation and escape from innate immune responses, with the potential of mitigating the severe immunopathogenic damage induced by highly pathogenic coronaviruses and restoring antiviral innate immune responses curtailed by viral infection.

microbiology↗